{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:55:08Z","timestamp":1781790908379,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00052"],"award-info":[{"award-number":["75N93019C00052"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008065","name":"Georgia Research Alliance","doi-asserted-by":"publisher","award":["GRA-001"],"award-info":[{"award-number":["GRA-001"]}],"id":[{"id":"10.13039\/100008065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.virol.2026.110787","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:04:56Z","timestamp":1767715496000},"page":"110787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adjuvants enhance protective antibodies against seasonal influenza viruses following a single vaccination of Fluzone"],"prefix":"10.1016","volume":"616","author":[{"given":"Matthew H.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Carlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1947-7469","authenticated-orcid":false,"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2026.110787_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122021","article-title":"Formulation of dry powders of vaccines containing MF59 or AddaVax by thin-film freeze-drying: towards a dry powder universal flu vaccine","volume":"624","author":"AboulFotouh","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.virol.2026.110787_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254421","article-title":"Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination","volume":"16","author":"Abreu","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.110787_bib3","series-title":"Cellular and Molecular Immunology","author":"Abul","year":"2018"},{"issue":"Suppl. 4","key":"10.1016\/j.virol.2026.110787_bib4","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110787_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/sji.12175","article-title":"On the mechanism determining the TH1\/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases","volume":"79","author":"Bretscher","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.virol.2026.110787_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301157","article-title":"Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons","volume":"19","author":"Carlock","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.110787_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-020-0626-6","article-title":"Better influenza vaccines: an industry perspective","volume":"27","author":"Chen","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.virol.2026.110787_bib8","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/cid\/ciz1034","article-title":"Comparative immunogenicity of several enhanced influenza vaccine options for older adults: a randomized, controlled trial","volume":"71","author":"Cowling","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110787_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/irv.12506","article-title":"Effects of seasonal and pandemic influenza on health-related quality of life, work and school absence in England: results from the flu watch cohort study","volume":"12","author":"Fragaszy","year":"2018","journal-title":"Influenza Other Respiratory Viruses"},{"key":"10.1016\/j.virol.2026.110787_bib10","article-title":"AddaVax-Adjuvanted H5N8 inactivated vaccine induces robust humoral immune response against different clades of H5 viruses","volume":"10","author":"Gao","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.110787_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01050-17","article-title":"Synthetic toll-like receptor 4 (TLR4) and TLR7 ligands work additively via MyD88 to induce protective antiviral immunity in mice","volume":"91","author":"Goff","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110787_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev-virology-010320-044746","article-title":"Challenges of making effective influenza vaccines","volume":"7","author":"Gouma","year":"2020","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.virol.2026.110787_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6803a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - united States, 2019-20 influenza season","volume":"68","author":"Grohskopf","year":"2019","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.virol.2026.110787_bib14","article-title":"Next generation influenza vaccines: looking into the crystal ball","volume":"8","author":"Guzm\u00e1n","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.110787_bib15","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/infdis\/jiae615","article-title":"Estimating standard-dose and high-dose fluzone vaccine efficacies for influenza A based on hemagglutination inhibition titers","volume":"231","author":"Hammerton","year":"2025","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110787_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007294","article-title":"Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets","volume":"15","author":"Hay","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.virol.2026.110787_bib17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.vaccine.2023.12.084","article-title":"Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection","volume":"42","author":"Huang","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110787_bib18","series-title":"Immunobiology: the Immune System in Health and Disease","author":"Janeway","year":"2001"},{"key":"10.1016\/j.virol.2026.110787_bib19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2026.110787_bib20","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.3390\/ijms25115909","article-title":"Recent insights into the molecular mechanisms of the toll-like receptor response to influenza virus infection","volume":"25","author":"Kayesh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2026.110787_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115909","article-title":"Recent insights into the molecular mechanisms of the toll-like receptor response to influenza virus infection","volume":"25","author":"Kayesh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2026.110787_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52687","article-title":"Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway","volume":"9","author":"Kim","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.virol.2026.110787_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/imr.12900","article-title":"Imprinting, immunodominance, and other impediments to generating broad influenza immunity","volume":"296","author":"Knight","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virol.2026.110787_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/362245a0","article-title":"Disruption of the murine IL-4 gene blocks Th2 cytokine responses","volume":"362","author":"Kopf","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.virol.2026.110787_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s44298-024-00038-0","article-title":"Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1","volume":"2","author":"Lathrop","year":"2024","journal-title":"Npj Viruses"},{"key":"10.1016\/j.virol.2026.110787_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4161\/hv.6.8.11563","article-title":"Pricing of new vaccines","volume":"6","author":"Lee","year":"2010","journal-title":"Hum. Vaccines"},{"key":"10.1016\/j.virol.2026.110787_bib27","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1016\/j.vaccine.2021.07.087","article-title":"Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection","volume":"39","author":"Li","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110787_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00705-024-06082-8","article-title":"A synthetic TLR4 agonist significantly increases humoral immune responses and the protective ability of an MDCK-cell-derived inactivated H7N9 vaccine in mice","volume":"169","author":"Luo","year":"2024","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2026.110787_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003875","article-title":"Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection","volume":"10","author":"Maroof","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2026.110787_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrmicro.2016.46","article-title":"Reassortment in segmented RNA viruses: mechanisms and outcomes","volume":"14","author":"McDonald","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2026.110787_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-023-00694-y","article-title":"A lipidated TLR7\/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice","volume":"8","author":"Miller","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virol.2026.110787_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fimmu.2020.00406","article-title":"Novel lipidated imidazoquinoline TLR7\/8 adjuvants elicit influenza-specific Th1 immune responses and protect against heterologous H3N2 influenza challenge in mice","volume":"11","author":"Miller","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.110787_bib33","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.1016\/j.vaccine.2018.10.088","article-title":"Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women","volume":"36","author":"Munoz","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110787_bib34","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1016\/j.vaccine.2020.05.059","article-title":"Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants","volume":"38","author":"Munoz","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110787_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/v15020347","article-title":"Adjuvant-mediated differences in antibody responses to computationally optimized hemagglutinin and neuraminidase vaccines","volume":"15","author":"Nagashima","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.110787_bib36","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis","volume":"378","author":"Nair","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2026.110787_bib37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni1223","article-title":"Selected toll-like receptor agonist combinations synergistically trigger a T helper type 1\u2013polarizing program in dendritic cells","volume":"6","author":"Napolitani","year":"2005","journal-title":"Nat. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2026.110787_bib38","doi-asserted-by":"crossref","first-page":"A56","DOI":"10.1016\/j.vaccine.2021.01.016","article-title":"Estimating public health and economic benefits along 10 years of Fluzone(R) high dose in the United States","volume":"39","author":"Net","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110787_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185666","article-title":"Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains","volume":"12","author":"Nunez","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.110787_bib40","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 - an innately attractive adjuvant formulation","volume":"30","author":"O'Hagan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110787_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41541-021-00418-0","article-title":"\"World in motion\" - emulsion adjuvants rising to meet the pandemic challenges","volume":"6","author":"O'Hagan","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virol.2026.110787_bib42","series-title":"Orthomyxoviridae: the Viruses and their Replication","first-page":"1647","article-title":"Fields virology","author":"Palese","year":"2007"},{"key":"10.1016\/j.virol.2026.110787_bib43","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4161\/hv.25363","article-title":"A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age","volume":"9","author":"Pavia-Ruz","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virol.2026.110787_bib44","series-title":"Influenza Vaccines \u2014 United States, 2019\u201320 Influenza Season","year":"2019"},{"key":"10.1016\/j.virol.2026.110787_bib45","series-title":"Influenza","year":"2024"},{"key":"10.1016\/j.virol.2026.110787_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-025-01350-3","article-title":"Integrated analysis of humoral and memory B-cell responses reveals distinct immune landscapes shaped by Influenza vaccine platforms","author":"Reis","year":"2025","journal-title":"NPJ Vaccines TBD"},{"key":"10.1016\/j.virol.2026.110787_bib47","article-title":"Kinetic of the antibody response following AddaVax-Adjuvanted immunization with recombinant influenza antigens","volume":"10","author":"Ross","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.110787_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071455","article-title":"Using dual toll-like receptor agonism to drive Th1-Biased response in a Squalene- and alpha-tocopherol-containing emulsion for a more effective SARS-CoV-2 vaccine","volume":"14","author":"Short","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.virol.2026.110787_bib49","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/pharmaceutics14071455","article-title":"Using dual toll-like receptor agonism to drive Th1-Biased response in a Squalene- and \u03b1-Tocopherol-Containing emulsion for a more effective SARS-CoV-2 vaccine","volume":"14","author":"Short","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.virol.2026.110787_bib50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2019.10.025","article-title":"Co-encapsulation of synthetic lipidated TLR4 and TLR7\/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity","volume":"315","author":"Short","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.virol.2026.110787_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2019.10.025","article-title":"Co-encapsulation of synthetic lipidated TLR4 and TLR7\/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity","volume":"315","author":"Short","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.virol.2026.110787_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/vaccines12010021","article-title":"Co-Delivery of novel synthetic TLR4 and TLR7\/8 ligands adsorbed to aluminum salts promotes Th1-Mediated immunity against poorly immunogenic SARS-CoV-2 RBD","volume":"12","author":"Siram","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.virol.2026.110787_bib53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.virol.2026.110787_bib54","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.3390\/app14125280","article-title":"Protective effect of Oyaksoongi-San against asthma induced by ovalbumin in a mouse model","volume":"14","author":"Song","year":"2024","journal-title":"Appl. Sci."},{"key":"10.1016\/j.virol.2026.110787_bib55","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/thx.51.5.496","article-title":"Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids","volume":"51","author":"Sont","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.virol.2026.110787_bib56","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0264-410X(02)00401-2","article-title":"Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects","volume":"21","author":"Squarcione","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110787_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1750-2659.2009.00073.x","article-title":"Estimates of US influenza-associated deaths made using four different methods","volume":"3","author":"Thompson","year":"2009","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.virol.2026.110787_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00354-24","article-title":"Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses","volume":"98","author":"Uno","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110787_bib59","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41598-023-51024-0","article-title":"Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses","volume":"14","author":"Uno","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2026.110787_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fphys.2018.00058","article-title":"Establishment and evaluation of a rat model of sidestream cigarette smoke-induced chronic obstructive pulmonary disease","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.virol.2026.110787_bib61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/irv.12604","article-title":"The impact of influenza infection on young children, their family and the health care system","volume":"13","author":"Willis","year":"2019","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.virol.2026.110787_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/cid\/cix269","article-title":"Differential effects of prior influenza exposures on H3N2 cross-reactivity of human postvaccination sera","volume":"65","author":"Xie","year":"2017","journal-title":"Clin. Infect. Dis."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:45:24Z","timestamp":1781790324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":62,"alternative-id":["S0042682226000024"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.110787","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvants enhance protective antibodies against seasonal influenza viruses following a single vaccination of Fluzone","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.110787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110787"}}